Today's top 5 stories on CNBC |
Pharma's Market w/ Mike Huckman: Dendreon's Provenge: The Latest On Cancer Drug CNBC's Mick Huckman Blogs on what's happening right now with Dendreon's Cancer Drug Provenge as the FDA considers approval, and what it all means for cancer patients. Click here to view posting. |
Tune in to CNBC tomorrow to watch the market unfold |
CNBC Investing Tools | |
To unsubscribe to this email click here
If this e-mail was forwarded to you and you would like to subscribe to CNBC's Daily Market Wrap, please click here
No comments:
Post a Comment